Dr. Sinclair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 E. State Street
Suite 301
Media, PA 19063Phone+1 610-892-1708Fax+1 610-892-8766- Is this information wrong?
Summary
- I am a board certified ophthalmologist specializing in surgical and medical treatment of vitreoretinal diseases.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Surgical Retina and Vitreous, 1978 - 1979
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1975 - 1977
- Massachusetts General HospitalInternship, Transitional Year, 1973 - 1974
- Harvard Medical SchoolClass of 1973
- Trinity CollegeMS, Biophysics, 1968 - 1969
- University of PennsylvaniaB.A., 1964 - 1968
Certifications & Licensure
- UT State Medical License 2019 - 2024
- PA State Medical License 1979 - 2021
- NJ State Medical License 1991 - 1995
- WI State Medical License 1978 - 1978
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Ecumenical Hospitaler Order Knights of St John of Malta 2012
- Senior Achievement Award American Academy of Ophthalmology, 2001
- Honor Award for Education American Academy of Ophthalmology, 1985
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsSlowed Progression of Age-Related Geographic Atrophy Following Subthreshold Laser.Jeffrey K. Luttrull, Stephen H. Sinclair, Solly Elmann, David B. Chang, David Kent> ;Clinical Ophthalmology. 2020 Oct 1
- 62 citationsDiabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes.Stephen H. Sinclair, Stanley Schwartz> ;Frontiers in Endocrinology. 2019 Dec 13
- 14 citationsLow incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD.Jeffrey K. Luttrull, Stephen H. Sinclair, Solly Elmann, Bert M. Glaser> ;PLOS ONE. 2018 Aug 23
- Join now to see all
Journal Articles
- Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathyZhang, J, Hu, L, Xu, G, Wu, Y, Shen, J, Luo, Y, Zhong, Y, Sinclair, SH, Yanoff, M, Li, W, Xu, G, Front. Biosci, 1/1/2010
- Screening Down athletes for ocular diseaseGutstein, W, Sinclair, SH, North, R., Bekiroglu, N, Optometry- Journal of the American Optometric Association, 1/1/2010
- Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular EdemaLi, W., S. Sinclair, GT. Xu, Ophthal Lasers, Imaging & Surgery, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Evaluation of Nuclear Cataract and Straylight on Central Vision Measured with the Central Vision Analyzer (CVA)Stephen H. Sinclair; Walter Gutstein, Rachel V. North, ARVO, 1/1/2012
- Evaluation of Monocular Neutral Density and Yellow Filters on Reading by Patients with Symptomatic Monocular MetamorphopsiaStephen H. Sinclair; Maryana Kravchenko, ARVO, 1/1/2012
- Micropulse Laser Treatment of Diabetic Macular EdemaStephen H. Sinclair, Majcher, Carolyn E., Li, Weiye, Presti, Peter, European Vitreo-retinal Society, Malta, 1/1/2011
- Join now to see all
Lectures
- Intravitreal Procrit in Eyes with Geographic Atrophy Secondary to ARMD Contiguous Grid Micropulse Laser for Diffuse Resistant Macular Edema associated with Diabetic Re...Cap Cana, DR - 2/28/2012
- Micropulse Laser Treatment of Diabetic Macular EdemaMalta - 9/30/2011
- Micropulse Contiguous Grid Laser in Eyes with Diffuse Macular Edema Due to Diabetic Retinopathy9/5/2011
- Join now to see all
Authored Content
- Should High Contrast Chart Acuity Continue to Be Used as a Functional Outcome for Clinical Trials of Macular Disease?August 2020
- Diabetic Retinopathy as a Predictor of Systemic Micro and Macrovascular ComplicationsAugust 2020
- Innovations to Assist in Pre-Retinal Membrane SurgeryAugust 2020
- Should High Contrast Chart Acuity Continue to Be Used as a Functional Outcome for Clinical Trials of Macular Disease?August 2020
- Diabetic Retinopathy as a Predictor of Systemic Micro and Macrovascular ComplicationsAugust 2020
- Innovations to Assist in Pre-Retinal Membrane SurgeryAugust 2020
- Join now to see all
Grant Support
- Blue Field Entoptic Test &Macular CirculationNational Eye Institute1987–1989
- Blue Field Entoptic Test &Macular CirculationNational Eye Institute1987
- Blue Field Entopic Test And Macular CirculationNational Eye Institute1985
Research History
- ConsultantMicrosoft Research- Accessibilities2019 - Present
- Sinclair TechnologiesPlease see website www.sinclairtechnologies.com2015 - Present
Professional Memberships
- Fellow
- Member
Hospital Affiliations
- Riddle HospitalMedia, Pennsylvania
Industry Relationships
- Consultant, Molecular Targeting Technologies, PSVueDevelopment of retinal targeting technologies2019 - Present
- CMO, GSX PharmaDevelopment of ophthalmic natriceuticals, oral screening assist program2015 - Present
- Board of Medical Advisors, InjectSenseDevelops miniaturized intraocular 24 x 7 pressure and other signals2015 - Present
- CEO, Sinclair TechnologiesMultiple diagnostic devices developed and brought through FDA approval, multiple drugs in processDisclosure: Multiple diagnostic devices2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: